<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92472">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01988454</url>
  </required_header>
  <id_info>
    <org_study_id>R2011-2103</org_study_id>
    <nct_id>NCT01988454</nct_id>
  </id_info>
  <brief_title>Characterization of Dyslipidemia in Adolescent Obesity</brief_title>
  <official_title>Characterization of Dyslipidemia in Adolescent Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Health Diagnostic Laboratory, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Health Diagnostic Laboratory, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this pilot study is to characterize the profile of lipoprotein,
      inflammatory, and metabolic markers of cardiovascular disease in obese adolescents as
      compared to normal-weight age-matched controls.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Comparison of biomarker profiles</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>To characterize and compare lipoprotein, inflammation and metabolic markers in obese and normal weight adolescents.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obesity</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole Blood and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Enrollment will be representative of the ethnic population of Charlotte, NC, estimated as
        50% Caucasian, 35% African American, 10% Hispanic, and 5 % other.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 13-19

          -  BMI â‰¥25 (obese) or &lt;25 (normal weight)

        Exclusion Criteria:

          -  Prior diagnosis of any eating disorder (e.g. anorexia or bulimia)

          -  Prior diagnosis of any congenital lipid disorder (e.g. familial hypercholesterolemia)

          -  Current use (or within past 6 months) of any lipid altering medications
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew D Acampora, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Stephen Varvel A. Varvel, PhD</last_name>
    <phone>804-343-2718</phone>
    <phone_ext>2231</phone_ext>
    <email>svarvel@hdlabinc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monique Alston, LPN</last_name>
    <phone>804-343-2718</phone>
    <phone_ext>2210</phone_ext>
    <email>malston@hdlabinc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Center for Nutrition and Preventive Medicine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Acampora, RN</last_name>
      <phone>704-364-4280</phone>
      <email>donna@cnpmcharlotte.com</email>
    </contact>
    <investigator>
      <last_name>Matthew D. Acampora, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010 Jan 20;303(3):242-9. doi: 10.1001/jama.2009.2012. Epub 2010 Jan 13.</citation>
    <PMID>20071470</PMID>
  </reference>
  <reference>
    <citation>Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998 Jun 4;338(23):1650-6.</citation>
    <PMID>9614255</PMID>
  </reference>
  <reference>
    <citation>Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992 Nov 5;327(19):1350-5.</citation>
    <PMID>1406836</PMID>
  </reference>
  <reference>
    <citation>Raitakari OT, Juonala M, Viikari JS. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study. Int J Obes (Lond). 2005 Sep;29 Suppl 2:S101-4.</citation>
    <PMID>16385760</PMID>
  </reference>
  <reference>
    <citation>Superko HR. Advanced lipoprotein testing and subfractionation are clinically useful. Circulation. 2009 May 5;119(17):2383-95. doi: 10.1161/CIRCULATIONAHA.108.809582. Review.</citation>
    <PMID>19414656</PMID>
  </reference>
  <reference>
    <citation>Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007 Jul;120(1):e189-214. Review.</citation>
    <PMID>17606543</PMID>
  </reference>
  <reference>
    <citation>Kang HS, Gutin B, Barbeau P, Litaker MS, Allison J, Le NA. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths. Int J Obes Relat Metab Disord. 2002 Aug;26(8):1030-5.</citation>
    <PMID>12119567</PMID>
  </reference>
  <reference>
    <citation>Miyashita M, Okada T, Kuromori Y, Harada K. LDL particle size, fat distribution and insulin resistance in obese children. Eur J Clin Nutr. 2006 Mar;60(3):416-20.</citation>
    <PMID>16278685</PMID>
  </reference>
  <reference>
    <citation>Kelishadi R, Cook SR, Amra B, Adibi A. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis. 2009 Jun;204(2):538-43. doi: 10.1016/j.atherosclerosis.2008.09.034. Epub 2008 Oct 9.</citation>
    <PMID>19013572</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 13, 2013</lastchanged_date>
  <firstreceived_date>November 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
